Nature reviews clinical oncology中文
Web17 de ago. de 2024 · 肿瘤学(ONCOLOGY)领域SCIE期刊及2024年影响因子排名part1 2024年08月17日 阅读数 19279 哪些肿瘤学(ONCOLOGY)SCI期刊容易发表? 影响因子是衡量期刊水平的重要指标,一般而言,影响因子较高的期刊投稿命中率较低,相对较难中,而影响因子较低的期刊则相对容易发表,为方便大家投稿时选刊,耐特译根据影响因子高 … Web《自然综述:药物发现》 Nature Reviews Drug Discovery 12 4900 《自然综述:心脏病学》 Nature Reviews Cardiology 12 3500 《自然综述:肠胃病学和肝脏病学》 Nature Reviews Gastroenterology & Hepatology 12 3500 《自然综述:临床肿瘤学》 Nature Reviews Clinical Oncology 12 3500
Nature reviews clinical oncology中文
Did you know?
WebNature Reviews Clinical Oncology 出版年份:2009 年文章数:41 投稿命中率:5.0% 出版周期:Monthly 自引率:1.3% 审稿周期:平均1.5月 WebNature Reviews Clinical Oncology is one of eight Clinical Review journals published by the Nature Publishing Group. It covers research developments and clinical practice in …
WebNature Reviews Clinical Oncology. Journal Abbreviation: NAT REV CLIN ONCOL. Journal ISSN: 1759-4774. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 … WebAbstract. Immunotherapy using T cells genetically engineered to express a chimeric antigen receptor (CAR) is rapidly emerging as a promising new treatment for haematological and non-haematological malignancies. CAR-T-cell therapy can induce rapid and durable clinical responses, but is associated with unique acute toxicities, which can be severe ...
Web18 de may. de 2024 · Lessons learned: the first consecutive 1000 patients of the CCCMunich LMU Molecular Tumor Board. Kathrin Heinrich. Lisa Miller-Phillips. C. Benedikt Westphalen. Original Article – Clinical Oncology. Open Access. Published: 07 July 2024. Pages: 1905 - 1915. WebNature Reviews Clinical Oncology. Journal Abbreviation: NAT REV CLIN ONCOL. Journal ISSN: 1759-4774. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) 65.011.
WebThe successes with chimeric antigen receptor (CAR) T cell therapy in early clinical trials involving patients with pre-B cell acute lymphoblastic leukaemia (ALL) or B cell lymphomas have revolutionized anticancer therapy, providing a potentially curative option for patients who are refractory to standard treatments.
WebNature Reviews Clinical Oncology is one of eight Clinical Review journals published by Nature Portfolio. It covers research developments and clinical practice in oncology. The … bully bunches coupon codeWebNature Reviews Clinical Oncology (Nat Rev Clin Oncol) ISSN 1759-4782 (online) ISSN 1759-4774 (print) nature.com sitemap. About Nature Portfolio. About us; Press … bully bunches couponWebEmerging evidence indicates that the efficacy of a given ADC depends on the intricacies of how the antibody, linker and payload components interact with the tumour and its microenvironment, all of which have important clinical implications. haka controversyWebnature reviews clinical oncology for authors For Authors Why write for Nature Reviews? Preparing your submission Editorial process Relationship to other Nature Research … haka communityWebIn this Review, we discuss the biology of NTRK fusions, strategies to target these drivers in the treatment-naive and acquired-resistance disease settings, and the unique safety profile of TRK inhibitors. Publication types Research … bully bunches bully sticksbully bunches reviewsWeb9 de abr. de 2024 · Nature Reviews Clinical Oncology is one of eight Clinical Review journals published by the Nature Publishing Group. It covers research developments and … bully bunches code